MAPK8 and non-small cell lung carcinoma: Recently, we found that Exosomes from SP600125 (JNK specific inhibitor)-treated non-small cell lung carcinoma (NSCLC) A549 cells (Exo-SP) inhibited human umbilical vein endothelial cells (HUVECs) tube formation.